Log in to save to my catalogue

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_524228

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

About this item

Full title

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

Publisher

American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2004-11, Vol.114 (9), p.1281-1289

Language

English

Formats

Publication information

Publisher

American Society for Clinical Investigation

More information

Scope and Contents

Contents

Adipose tissue plays a central role in the control of energy homeostasis through the storage and turnover of triglycerides and through the secretion of factors that affect satiety and fuel utilization. Agents that enhance insulin sensitivity, such as rosiglitazone, appear to exert their therapeutic effect through adipose tissue, but the precise mec...

Alternative Titles

Full title

Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_524228

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_524228

Other Identifiers

ISSN

0021-9738

DOI

10.1172/JCI200421752

How to access this item